{"id":"W2167984747","doi":"10.1111/j.1524-4733.2010.00738.x","title":"How Do Cost-Effectiveness Analyses Inform Reimbursement Decisions for Oncology Medicines in Canada? The Example of Sunitinib for First-Line Treatment of Metastatic Renal Cell Carcinoma","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Sunitinib; Reimbursement; Medicine; Context (archaeology); Oncology; Internal medicine; Tyrosine-kinase inhibitor; Sorafenib; Renal cell carcinoma; Cabozantinib; Kidney cancer; Cancer; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001265591,0.0002383794,0.001062585,0.0003281386,0.00007701174,0.000005070284,0.0001363961,0.00006240392,0.00001314544],"category_scores_gemma":[0.0005357412,0.0001462589,0.0001595911,0.0003731824,0.0001003127,0.00003512726,0.0000230956,0.0001384587,1.269061e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001816976,"about_ca_system_score_gemma":0.004841865,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8411701,"about_ca_topic_score_gemma":0.8282159,"domain_scores_codex":[0.9977392,0.0002221268,0.0009232595,0.0003021434,0.0003660012,0.0004472444],"domain_scores_gemma":[0.9920471,0.006468268,0.0004984791,0.0005159669,0.0002708878,0.000199314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02025146,0.01201203,0.5066874,0.01346735,0.001408878,0.0004531874,0.01654721,0.04295068,0.02564737,0.004093857,0.001778503,0.3547021],"study_design_scores_gemma":[0.05878861,0.0506799,0.5897003,0.001457276,0.001440263,0.0001431909,0.007524781,0.01337274,0.2401026,0.001711881,0.03452374,0.0005547058],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881254,0.001416553,0.0005599273,0.003092868,0.0002204531,0.006298867,0.000212761,0.000004165272,0.00006898215],"genre_scores_gemma":[0.9949027,0.0002884371,0.002969448,0.0001031501,0.00006373369,0.00147221,0.0001476846,0.00002404404,0.00002855285],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3541474,"threshold_uncertainty_score":0.8589261,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.261720571965914,"score_gpt":0.4142385738600041,"score_spread":0.15251800189409,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}